« Back to Record
Tabchi, S., Kourie Hampig, R., & Kattan, J. (2016). Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy. Investigational new drugs, 34(6), 794-796. doi:10.1007/s10637-016-0383-2
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/248232



